Breaking News, Promotions & Moves

Curevo Vaccine Names Guy De La Rosa Chief Medical Officer

Brings 20 years of big pharma and biotech infectious disease clinical trial experience.

Curevo Vaccine, a privately held clinical-stage biotechnology company dedicated to reducing the burden of infectious disease by developing safe and highly effective vaccines, announced Guy De La Rosa has joined the company as its new chief medical officer. “The Curevo team is excited to welcome Dr. De La Rosa to the company,” said George Simeon, Curevo’s CEO. “Guy, with his 20-plus years of experience directing clinical trials in the infectious disease space, will immediately bring a positive...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters